KRAS and pachyonychia congenita: Targeting pyruvate dehydrogenase kinase 4 in glucose metabolism also interferes with lipid metabolism and promotes ROS production, thereby reducing the proliferation of KRAS mutation-driven PC cells (Terado et al., 2022).